Cleared Abbreviated

K022501 - INSTANT-VIEW MDMA (ECSTASY

K022501 is the FDA 510(k) clearance for INSTANT-VIEW MDMA (ECSTASY by Alfa Scientific Designs, Inc.. It is a Class 2 Toxicology device (product code DJC) cleared through the Abbreviated 510(k) pathway after a 107-day FDA review.

K022501 · Alfa Scientific Designs, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
107d
Days
Class 2
Risk

K022501 is an FDA 510(k) clearance for the INSTANT-VIEW MDMA (ECSTASY, XTC) URINE TEST. Classified as Thin Layer Chromatography, Methamphetamine (product code DJC), Class II - Special Controls.

Submitted by Alfa Scientific Designs, Inc. (Poway, US). The FDA issued a Cleared decision on November 13, 2002 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3610 - the FDA toxicology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Alfa Scientific Designs, Inc. devices

Submission Details

510(k) Number K022501 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2002
Decision Date November 13, 2002
Days to Decision 107 days
Submission Type Abbreviated
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 87d · This submission: 107d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DJC Thin Layer Chromatography, Methamphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3610
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DJC Thin Layer Chromatography, Methamphetamine

All 14
Devices cleared under the same product code (DJC) and FDA review panel - the closest regulatory comparables to K022501.
OralTox Oral fluid Drug Test
K181305 · Premier Biotech, Inc. · Sep 2018
OralTox Oral Fluid Drug Test
K171403 · Premier Biotech, Inc. · Feb 2018
WONDFO OXAZEPAM URINE TEST (BZO 200) AND WONDFO METHAMPHETAMINE URINE TEST (MET 300)
K132630 · Guangzhou Wondfo Biotech Co., Ltd. · Sep 2013
INSTANT-VIEW METHAMPHETAMINE URINE DIP STRIP TEST
K994406 · Alfa Scientific Designs, Inc. · Aug 2000
INSTANT-VIEW METHAMPHETAMINE URINE CASSETTE TEST
K994400 · Alfa Scientific Designs, Inc. · Aug 2000
ONTRAK TESTCUP PRO-5, MODEL 1986678
K001356 · Roche Diagnostics Corp. · Jul 2000